Mutual Fund Details – Invest Smart, Grow Wealth
Discover a variety of mutual funds tailored to your goals, from equity and debt to hybrid options. Track performance, compare funds, and get expert insights to make informed investment decisions. Grow your wealth with Motilal Oswal’s trusted mutual fund solutions.
Nippon India Pharma Fund-Growth
Equity, Sectoral-Pharma, Principal at very high risk
1 Year Return 8.06%
Fund Details
NAV 508.7629
Sub-Type Sectoral-Pharma
Rating 3
Min. SIP Amount 100.0
Fund Age(Year) 21.71
Fund Size 7875.4
Fund Performance
1 Month 1.61%
3 Month -1.73%
6 Month -2.59%
1 Year 8.06%
3 Year 22.97%
5 Year 15.04%
Comparison with same funds
Equity, Flexi Cap funds Aditya Birla Sun Life Pharma & Healthcare Fund Regular-Growth Ret 1M 1.24% Ret 1Y 8.05% Ret 3Y 22.64% Ret 5Y 13.71%
Equity, Flexi Cap funds Aditya Birla Sun Life Pharma & Healthcare Fund Regular-IDCW Ret 1M 1.24% Ret 1Y 8.05% Ret 3Y 22.64% Ret 5Y 13.71%
Equity, Flexi Cap funds Aditya Birla Sun Life Pharma & Healthcare Fund Regular-IDCW Reinvestment Ret 1M 1.24% Ret 1Y 8.05% Ret 3Y 22.64% Ret 5Y 13.71%
Equity, Flexi Cap funds Bajaj Finserv Healthcare Fund Regular-Growth Ret 1M 0.29% Ret 1Y 6.73% Ret 3Y 0% Ret 5Y 0%
Equity, Flexi Cap funds Bajaj Finserv Healthcare Fund Regular-IDCW Payout Ret 1M 0.29% Ret 1Y 6.73% Ret 3Y 0% Ret 5Y 0%
Equity, Flexi Cap funds Bajaj Finserv Healthcare Fund Regular-IDCW Reinvestment Ret 1M 0.29% Ret 1Y 6.73% Ret 3Y 0% Ret 5Y 0%
Equity, Flexi Cap funds Bandhan BSE Healthcare Index Fund Regular-Growth Ret 1M 1.12% Ret 1Y 7.08% Ret 3Y 0% Ret 5Y 0%
Equity, Flexi Cap funds Bandhan Healthcare Fund Regular - Growth Ret 1M 0.81% Ret 1Y 0% Ret 3Y 0% Ret 5Y 0%
Equity, Flexi Cap funds Bandhan Healthcare Fund Regular - IDCW Ret 1M 0.81% Ret 1Y 0% Ret 3Y 0% Ret 5Y 0%
Equity, Flexi Cap funds Bandhan Healthcare Fund Regular - IDCW Reinvestment Ret 1M 0.81% Ret 1Y 0% Ret 3Y 0% Ret 5Y 0%
Equity, Flexi Cap funds Baroda BNP Paribas Health and Wellness Fund Regular-Growth Ret 1M 1.33% Ret 1Y 0% Ret 3Y 0% Ret 5Y 0%
Charges & Taxes Expense Ratio
Returns are taxed as per your Income Tax Slab.
Expense Ratio (Inclusive of GST): 1.81%
Exit Load 0%
Stamp Duty 0.005%
Fund Management
The various expenses, charges and taxes associated with your Mutual Fund
Sailesh Raj Bhan
Education Mr. Bhan is an MBA (Finance) and CFA.
Experience Prior to joining Nippon India Mutual Fund, he has worked with Emkay Share & Stock Broker Pvt. Ltd, Shah & Sequeira Invst. Pvt. Ltd, ICFAI- Securities Research Center Analyst - Equity Research.
Divya Dutt Sharma
Education Bachelor of Commerce, MSC Banking & Finance.
Experience Prior to joining the Nippon AMC, he was associated with Bhramrishi Mission NGO, Equations LLC, V.K Pamecha and Associates.
Lokesh Maru
Education Bachelor of Technology, CFA, FRM
Experience Prior to joining the Nippon AMC, he was associated with BlackRock Services India Private Ltd, CRISIL Ltd.
Riskometer
Mutual Fund Investments are subject to market risk. Read all scheme related documents carefully.
Principal at very high risk%
AMC and Fund details
Rank (total sets) 8
Date of Incorporation 2004-06-05
Total AUM 2026-01-31
The Scheme Seeks to generate returns from a portfolio of pure debt oriented funds accessed through the diverse investment styles of underlying schemes selected in accordance with the BSLAMC process.
Know This Fund
As on 19 Feb 2026
Investment strategy that balances risk & reward by dividing the investment portfolio among different types of asset classes.
Equity (98.96%) Market Cap Small Cap 28.88 Mid Cap 45.14 Large Cap 24.94 Top Sectors Healthcare 98.96 Top Holding Sun Pharmaceutical Industries 12.67 Akums Drugs And Pharmaceuticals 0.85 Glaxosmithkline Pharma 2.78 Narayana Hrudayalaya 2.07 Syngene International 1.13 Medplus Health Services 3.68 Alkem Laboratories 2.33 Thyrocare Technologies 2.34 JB Chemicals 2.37 Aurobindo Pharma 2.61 Vijaya Diagnostic Centre 3.51 Sanofi Consumer Healthcare India 1.15 Fortis Healthcare 1.19 Max Healthcare Institute 1.51 Lupin 7.88 Emcure Pharmaceuticals 1.39 Astrazeneca Pharma India 0.68 Anthem Biosciences 0.81 Gland Pharma 1.88 Apollo Hospitals Enterprise 5.73 Suraksha Diagnostic 1.32 Divi's Laboratories 6.54 Concord Biotech 0.17 Indoco Remedies 0.51 Biocon 1.03 Abbott India 2.6 Sai Life Sciences 2.71 Cipla 5.88 Pfizer 1.84 Dr. Reddy's Laboratories 6.06 Ajanta Pharma 3.39 Dr. Lal Pathlabs 2.18 Ipca Laboratories 2.55 Sanofi India 1.17 Mankind Pharma 2.45
Debt & Others (1.04%) Sector Allocation Margin Money 0 Net Payables -0.11 Repo 1.15 Debt Credit Ratings Debt Category Others 1.04
Take Your Next Step
